In Reply to the Letter to the Editor: The Efficacy of Denosumab for Prevention of Early Periprosthetic Bone Loss After Cementless Total Hip Arthroplasty

J Bone Miner Res. 2020 May;35(5):1000. doi: 10.1002/jbmr.3981. Epub 2020 Mar 2.

Authors

Andreas Nyström¹, Nils P Hailer¹, Hans Mallmin¹

Affiliation

¹ Department of Surgical Sciences, Section of Orthopaedics, Uppsala University, Uppsala, Sweden.

PMID: 32119746
DOI: 10.1002/jbmr.3981

No abstract available

Publication types

Letter
Comment

MeSH terms

Arthroplasty, Replacement, Hip* / adverse effects
Bone Diseases, Metabolic*
Denosumab / therapeutic use
Humans
Osteoporosis*

Substances

Denosumab